Genetic testing as first step in chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether genetic testing early in the care of chronic kidney disease can help find the cause. It may help guide treatment and let family members know if they are at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease (CKD) and have been referred to a kidney specialist.
- You or your doctor have determined that your kidney disease might be genetic (based on a provincial screening).
- You are able to give informed consent, or someone can give consent for you.
- If you're a family member or caregiver, the related patient must be enrolled in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny genetic pieces in your blood to find markers that might help track kidney disease. If you join, researchers will compare these markers between healthy people, people with high blood pressure, and people with chronic kidney disease.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
This study looks at how genetics affect the progression of kidney diseases. Joining may help researchers understand your condition better and find better treatments.
This study uses genetic testing to look for inherited (“monogenic”) reasons some people get kidney stones. It may help explain the cause of stones and calcium-related problems, which can guide future care for you or your family.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
Hear when a new Chronic Kidney Disease(CKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.